baber/WOPTO huggingface dataset:
Patent DK-1669500-T3 (DK)
Inventor: STIEHL OLIVER
IPC: E03F9/00
Filed: 2004-12-08
Granted: 2011-01-24
Abstract: The device has a flushing plate (3) moveable between lowered and raised positions, where plate lies at a wall region (4) during lowered position and releases a part of a channel section during raised position. The plate has a flexible seal (11) in a region that contact with the region (4). The seal has a base section (14) held in a plate body, and a lip section situated outside of the plate body to attach at the wall region.
Patent DK-1627232-T3 (DK)
Inventor: CARLSEN THOMAS NIKOLAI
IPC: G01N35/10
Filed: 2004-05-19
Granted: 2008-03-10
Abstract: The present invention relates generally to an apparatus for analysing fluid taken from a body, and more in particularly for analysing body fluids from mammals. The analysis apparatus is coupled to a dairy system for milking of cows, wherein it useful to analyse the status of the milk. The apparatus is preferably located as early as possible in the production chain in order to obtain results as close as possible to the cows. Hence the environment in which the apparatus is to be used may be harsh towards internal apparatus modules or consumables, therefore the apparatus is isolated and the internal environment is conditioned regarding humidity, temperature as well as the amount of ammonium. Furthermore the steps for analysing milk is automated inside the apparatus in order to avoid influence from the external environment.
Patent DK-1661905-T3 (DK)
Inventor: IMANISHI TAKESHI
IPC: C12N15/00
Filed: 2004-08-25
Granted: 2012-07-23
Abstract: It is intended to provide oligonucleotide analogs usable in, for exmaple, the antisense method which are highly tolerant to enzymes, have a strong and selective binding affinity for a single-stranded RNA and also are highly capable of forming a triple-strand in a double-stranded DNA, and nucleoside analogs useful for producing the same. Namely, a nucleoside analog which is a compound represented by the following general formula (I) or its salt and an oligonucleotide analog containing one or more of the same:   
wherein Base represents an optionally substituted aromatic heterocyclic group, etc.: R 1 , R 2  and R 3  represent each a hydrogen atom, an amino-protecting group, a hydroyl-protecting group, a phosphate group or -P (R 4 )R 5  [wherein R 4  and R 5  represent each a hydroxyl group, a protecting group, an optionally protected mercapto group, etc,]; m is from 0 to 2; and n is from 1 to 3.
Patent DK-1893496-T3 (DK)
Inventor: SILVERS KERRY W
IPC: B65D1/02
Filed: 2005-06-13
Granted: 2010-11-08
Abstract: A plastic container having a base portion adapted for vacuum pressure absorption. The base portion including a contact ring upon which the container is supported, an upstanding wall and a central portion. The upstanding wall being adjacent to and generally circumscribing the contact ring. The central portion being defined in at least part by a central pushup and an inversion ring which generally circumscribes the central pushup. The central pushup and the inversion ring being moveable to accommodate vacuum forces generated within the container.
Patent DK-1842466-T3 (DK)
Inventor: MUELLER GEORG
IPC: A47J31/08
Filed: 2007-03-05
Granted: 2009-04-20
Abstract: The filter insert (11) includes a conical filter body with stamped seams (7, 8) and an aperture (9) for filling with ground coffee. The filter body contains at least one strip (3) with markings (12) and/or aromatic materials. The filter insert is produced by laying the strip on the filtering material and folding, cutting and stamping the filtering material.
Patent DK-2170739-T3 (DK)
Inventor: SCHINASI PIERO
IPC: B65D88/16
Filed: 2008-07-16
Granted: 2011-07-18
Abstract: The invention relates to a bag for transporting and handling liquid or quasi liquid substances, that comprises at least a bottom and four sides and optionally a lid. The bag is provided with a sealed inner envelope including filling and optionally draining members. The bag also includes reinforcement plates integrated in the sides and the lid of the bag and optionally in the bottom of the bag. The bag is further provided with members for lifting same. The bag is particularly characterised in that the four sides of the bag include at the upper portions thereof an overhanging collar (2) oriented towards the inside, the four tails of the collar being connected at their adjacent edges along common ridges (3) oriented as in a pyramid, and in that the lifting members include, on the one hand, lifting straps (7) including a section (7d) sawn on the above-mentioned ridges (3) of the collar so that each strap, also sawn on the vertical ridges of the four corners of the bag (7a), includes a section (7d) oriented back into the bag along said ridge (3) and, on the other hand, a tube or duct (8) connected at least to the straps grouped by pairs.
Patent DK-2231131-T3 (DK)
Inventor: GUERRET OLIVIER
IPC: A61K9/51
Filed: 2008-10-07
Granted: 2011-04-26
Abstract: The invention consists of formulations based on compounds of platinum encapsulated by associative and water-soluble polymers. These formulations are in aqueous form or in the form of granulates. The invention further pertains to pharmaceutical preparations which contain these formulations, and their implementation in the fabrication of an orally administered medication, in polychemotherapy treatments.
Patent DK-2080451-T3 (DK)
Inventor: KIMMERLE MICHAEL
IPC: A47C7/54
Filed: 2009-01-05
Granted: 2012-04-23
Abstract: The pivoting arm rest has a pivoting section (2) opposite to a chair, and a rotating section (40) that is twisting opposite to the pivoting section. A carrier element (200) is provided for rotating carrier of the pivoting section at the chair. A blocking element (7) is provided, which is designed such that the pivoting section of the arm rest is swiveled only against the chair when the rotating section of the armrest adopts a pre-defined position opposite to the pivoting section.
Patent DK-2319517-T3 (DK)
Inventor: RABINOVICH-GUILATT LAURA
IPC: A61K31/573
Filed: 2006-06-01
Granted: 2013-12-09
Abstract: Use of a composition comprising at least one prodrug of a steroid, preferably of a corticosteroid, for the preparation of an ophthalmic composition intended for the treatment of an ocular condition or disease of a human being or an animal.
Patent DK-2501448-T3 (DK)
Inventor: BURGER GUENTER
IPC: A63G3/00
Filed: 2010-11-17
Granted: 2013-12-09
Abstract: The invention relates to a water amusement ride (1), comprising at least one water vehicle (20) that can be moved in a body of water and a floating body (23) that is carried by water, having seats for accommodating passengers, wherein a platform (10) is provided, which extends out of the water surface (4) of the body of water when the water amusement ride (1) is in an idle state and is beneath the water surface (4) when in operation. An advantage of said invention is that the passengers can reach their seats in the water vehicles without getting wet feet when the water amusement ride is in an idle state.
Patent DK-2410053-T3 (DK)
Title: The antisense compounds
Inventor: SWAYZE ERIC E
IPC: C12N15/113
Filed: 2007-10-18
Granted: 2014-12-08
Abstract: Provided herein are gapmer oligomeric compounds for reduction of target RNA in vivo comprising different nucleotide modifications within one or both wing regions. Also provided are methods of using such oligomeric compounds, including use in animals. In certain embodiments, such compound have desirable potency and toxicity characteristics.
Patent DK-2699620-T3 (DK)
Inventor: WELLINGS DONALD
IPC: C12N11/02
Filed: 2012-04-20
Granted: 2018-06-18
Abstract: The invention provides a cross-linked poly-Îµ-lysine polymer. The poly-Îµ-lysine and cross linker are linked by amide bonds and may the cross linker has at least two functional groups capable of reacting with an alpha carbon amine of poly-Îµ-lysine. The polymer is suitably insoluble in water and other solvents and is provided in particulate form. The invention provides a particulate support comprising the cross-linked poly-Îµ-lysine polymer and the polymer may provide the particle itself or be coated on a particle for example silica. The polymer is useful in a wide range of applications including wound treatment, as a medical diagnostic comprising a particulate support and a functional material bound or retained by the support and solid phase synthesis of peptides, oligonucleotides, oligosaccharides, immobilisation of species, cell culturing and in chromatographic separation.
Patent DK-2753687-T3 (DK)
Inventor: MOGNA GIOVANNI
IPC: C12N1/20
Filed: 2012-09-10
Granted: 2018-05-28
Abstract: The present invention refers to strains of lactic bacteria and/or bifidobacteria having activity of inhibiting/reducing the growth of different biotypes of E.coli, including E.coli O157:7 and different biotypes of clostridia, including Clostridium difficile, Listeria monocytogenes, Enterococcus sp. and Klebsiella sp. Furthermore, the present invention refers to a pharmaceutical or dietary composition or a supplement or a medical device comprising at least one of the said strains of bacteria, optionally in combination with acetylcysteine and/or microencapsulated gastroprotected lysozyme and/or acetylcysteine with microencapsulated gastroprotected lysozyme.
Patent DK-0378146-T3 (DK)
Inventor: STEMERICK DAVID M
IPC: C07C211/09
Filed: 1990-01-08
Granted: 1995-05-01
Abstract: This invention relates to compounds of formula I  RHN-Z-NH-(CH2)m-NH-Z-NHR      (I). These compounds are particularly useful for treating a patient suffering from a neoplastic disease state. The compounds of formula I, may also be administered in a conjunctive therapy with a polyamine oxidase inhibitor.
Patent DK-0415068-T3 (DK)
Inventor: KUNZ PETER
IPC: B29L23/00
Filed: 1990-07-21
Granted: 1996-07-22
Abstract: Arranged on the outer circumference of the tubular thermoplastic elements (1a, 1b) to be joined is a supporting shell (3) of a material which allows infrared rays to pass through, such as for example quartz glass. Arranged around the supporting shell (3) is an infrared radiation heat source (6), the heating rays of which penetrate the supporting shell (3) and plastify the ends of the tubular elements (1a, 1b) for welding. Arranged on the inner circumference of the tubular elements (1a, 1b) is a supporting device (4), which ensures the build-up of the required welding pressure and ensures welding without any beads or grooves. <IMAGE>
Patent DK-0429318-T3 (DK)
Inventor: DARDAINE EDGAR
IPC: B65B7/28
Filed: 1990-10-25
Granted: 1993-12-13
Abstract: The present invention concerns a method and apparatus for transferring lids in a machine for sterile packaging of containers. 
<??>The apparatus of this invention essentially comprises two elongated clamp-holder units substantially parallel (5, 8) and penetrating by one end into a sterile enclosure (E) for the packaging of containers, one (5) of these two units being able to be driven, in its longitudinal direction, with an alternating motion with respect to the other clamp-holder unit (8) which remains fixed in translation. 
<??>This device allows, in particular, the transfer, positioning and temporary fixing of lids of any shape and size on containers or goblets filled with any produce. 
<IMAGE>
Patent DK-0483902-T3 (DK)
Inventor: DALIN IVAN
IPC: D21H17/67
Filed: 1991-10-21
Granted: 1994-04-18
Abstract: The invention concerns a method of bleaching particles containing calcium carbonate by keeping them in contact with an aqueous solution containing hydrogen peroxide and having a pH-value below 8.
Patent DK-0513104-T3 (DK)
Inventor: BONTE FREDERIC
IPC: A61K8/00
Filed: 1991-01-30
Granted: 1996-05-20
Abstract: Use of an  alpha -tocopheryl phosphate, in particular in the dl or d form thereof, or one of the esters thereof, of general formula: <IMAGE>  in which:   - R1 represents a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, in particular such as the methyl or ethyl radical, or an  alpha -tocopheryl radical; - R2 represents a hydrogen atom, an alkyl radical having from 1 to 4 carbon atoms, in particular such as a methyl or ethyl radical, or alternatively R2O represents an oxyethylenated chain, of formula <IMAGE> in which R3 and R4 independently represent a hydrogen atom or a methyl radical, and n represents an integer greater than or equal to 1;  or one of the salts thereof, for the preparation of a pharmaceutical, dermatological or cosmetic composition intended for the prevention or treatment of the harmful effects of free radicals, or as a cosmetic agent for combating free radicals.
Patent DK-0539442-T3 (DK)
Inventor: RAHIM SAAD GEORGE
IPC: A61P31/12
Filed: 1991-07-18
Granted: 1998-09-07
Abstract: The use of a uracil compound substituted in the 5-position by an iodine; bromine; a C2-4 alkenyl group; a C2-6 alkynyl group optionally substituted by a halogen atom; a cyano group; or a C1-4 alkyl group substituted by halogen in the manufacture of a medicament for use as a uracil reductase inactivator, with the provisio that the uracil reductase inactivator is not 5-ethynyluracil, or a prodrug thereof.
Patent DK-0540577-T3 (DK)
Inventor: GERBER JAN
IPC: A61B10/00
Filed: 1991-07-18
Granted: 1994-05-30
Abstract: PCT No. PCT/NL91/00129 Sec. 371 Date Jan. 13, 1993 Sec. 102(e) Date Jan. 13, 1993 PCT Filed Jul. 18, 1991 PCT Pub. No. WO92/01421 PCT Pub. Date Feb. 6, 1992.A diagnostic testing device for the skin, comprising at least one compartment (3) for the accommodation of a diagnostic aid, and adhesive strip (1) on which the compartment is accommodated, and a removable protective strip (4) which is stuck to the adhesive strip at the same side as the compartment. The protective strip is provided with an opening (7) at the position of each compartment.
Patent DK-0559688-T3 (DK)
Inventor: LEINEN HANS-THEO
IPC: A01N43/50
Filed: 1991-11-18
Granted: 1996-07-08
Abstract: Fungicidal solutions containing 2,4,5,6-tetrachloroisophthalodinitrile are provided. The solutions are prepared by dissolving from 5% to 12% by weight of 2,4,5,6-tetrachloroisophthalodinitrile in 1,3-dimethyl-2-imidazolidinone. The solutions are clear and can be stirred without streaking or sedimentation into water-based paints or lacquers or solvent-containing paints or lacquers.
Patent DK-0496420-T3 (DK)
Inventor: SKORPENSKE RICHARD GLEN
IPC: C08J9/02
Filed: 1992-01-24
Granted: 1997-04-07
Abstract: Disclosed is an active hydrogen-containing composition suitable for the production of flexible polyurethane foam when reacted with a polyisocyanate, said composition comprising,   (a) a polyol having an average functionality of 2.0 to 4.0, and an equivalent weight in the range of from 500 to 5000; (b) from 0.5 to 5 parts, per 100 parts by weight of component (a), of a crosslinker selected from monoethanolamine, diethanolamine, triethanolamine, monoisopropanolamine, diisopropanolamine, methylene bis(o-chloroaniline) and mixtures thereof; and (c) from 0.3 to 15 parts per 100 parts by weight of component (a), of a compound having at least 3 hydroxyl groups, at least two of which are secondary hydroxyl groups; and an equivalent weight of less than about 500; as well as flexible polyurethane foams prepared therefrom. The active hydrogen-containing composition of the invention has been discovered to be useful in the production of polyurethane foams which are advantageously able to pass certain standard laboratory flammability tests.
Patent DK-0501842-T3 (DK)
Inventor: GROSHENS PIERRE
IPC: D04H13/00
Filed: 1992-01-24
Granted: 1996-06-03
Abstract: The invention relates to the sector of textile reinforcements or interlinings. 
<??>It relates more specifically to a textile interlining comprising a first nonwoven layer (1) composed of microfibres produced by melt-blowing. 
<??>According to the invention, it comprises a second nonwoven layer (2) composed of fibres or filaments. The first layer (1) and the second layer (2) are connected by the entanglement of some of their fibres which is obtained by the application of fluid jets. 
<IMAGE>
Patent DK-0646594-T3 (DK)
Inventor: LUSK LANCE T
IPC: C07K14/62
Filed: 1993-10-02
Granted: 1997-12-22
Abstract: A method of removing a valuable protein from a complex solution and recovering the valuable protein in purified form consists of adding a silica gel sorbant having a pore size approximately the molecular size of the protein to a solution containing the protein, allowing the protein to be sorbed onto the sorbant, separating the sorbant from the solution and then recovering the protein from the sorbant.
Patent DK-0574318-T3 (DK)
Inventor: BUENDIA JEAN
IPC: C07B61/00
Filed: 1993-06-10
Granted: 1996-07-29
Abstract: The invention relates to a new process for preparing the compounds of formula (I): <IMAGE> in which the rings A and B represent a 3-keto- DELTA <4>-6-R3, optionally in a form protected in position 3, or 3-keto- DELTA <1,4>-6-R3, R is methyl or -CH2OR' where R' is hydrogen or an ether or ester residue, R1 and R2 form a  beta  epoxide, a second bond, or R1 is hydrogen, ketone, or hydroxy in  alpha  or  beta , optionally in etherified or esterified form, and R2 is hydrogen, or R1 is hydrogen and R2 is  alpha -hydroxy, or R1 is  beta -hydroxy optionally etherified or esterified and R2 is a fluorine or a bromine in  alpha , and R3 is hydrogen, fluorine or methyl in  alpha  or beta , according to which a  DELTA <16(17)> derivative is treated with a methylating agent, followed by intermediate hydrolysis and the enol thus obtained is oxidised by molecular oxygen in the presence of an appropriate reducing agent. The compounds (I) are known anti-inflammatory agents or possible precursors.
Patent DK-0570574-T3 (DK)
Inventor: SIMON JAIME
IPC: C07F9/6561
Filed: 1992-12-10
Granted: 1999-08-16
Abstract: Complexes of bicyclopolyazamacrocyclophosphonic acid compounds with a metal ion, e.g. 153Sm, 177Lu, 159Gd, 149Pm, 140La, 175Yb, 166Ho, 90Y, 47Sc, 186Re, 188Re, 142Pr, 99mTc, 67Ga, 68Ga, 105Rh, 97Ru, 111In, 113mIn or 115mIn ion, are disclosed. The complexes can be covalently attached to a biologically active molecule, e.g. an antibody or antibody fragment, to form conjugates. The complexes and conjugates are useful as radiopharmaceutical agents for therapy and/or diagnostic purposes.
Patent DK-0656968-T3 (DK)
Inventor: TROKHAN PAUL DENNIS
IPC: D21F3/00
Filed: 1993-08-16
Granted: 1999-06-23
Abstract: A secondary belt for papermaking. The belt has a framework of protuberances arranged in a semicontinuous pattern to provide a semicontinuous pattern of deflection conduits. The semicontinuous pattern is distinguished from the discrete and continuous patterns of the prior art. The protuberances may be generally parallel, or may provide individual cells within the deflection conduits between the protuberances. Also disclosed is the paper made on such a secondary belt. <IMAGE>
Patent DK-0664931-T3 (DK)
Inventor: ZITO RALPH
IPC: H01M8/04
Filed: 1993-10-13
Granted: 1997-12-08
Abstract: An electrochemical process for energy storage and power generation comprises a single cell or an array of unit cells (10), each cell comprising a +<ve> electrode (12) and a -<ve> electrode (14) with a membrane in each cell dividing it into +<ve> and -<ve> chambers (22C and 24C) for posilyte and anolyte solutions (22, 24) which are recirculated through separate pumps (26, 28) and storage tanks (32, 34) and back to the chambers. An iron-sulfur couple is employed, the overall reaction being: 2Fe<3+> + S<2-> = 2Fe<2+> + S(Eq.8), the Fe<3+> ions being provided as the chloride, bromide or iodide and the sulfide being provided as the sodium, potassium, lithium or ammonium salts. The +<ve> chamber contains a soluble ionic salt which acts as a charge carrier during energy storage, preferably sodium or potassium chloride. Means are provided to offset pH in the system, and further means are provided for a third chamber (23C) whereby the system is more effectively electrically rechargeable.
Patent DK-0637620-T3 (DK)
Inventor: POELLMANN KLAUS DR
IPC: C09K3/00
Filed: 1994-07-30
Granted: 1999-08-16
Abstract: According to the method described, the used aircraft deicing fluid is first subjected to conventional filtration for separating off undissolved substances and then to an ultrafiltration for separating off, in particular, polymeric thickeners. The ultrafiltration permeate is further treated with ionic exchangers and water is then separated off by distillation from the eluate obtained essentially comprising glycol and water and thus the glycol level is brought to the desired value. A new aircraft deicing composition can be prepared with the glycol/water solution thus obtained by adding the additional necessary components to the glycol/water solution.
Patent DK-0652287-T3 (DK)
Inventor: WASMOEN TERRI
IPC: A61K39/275
Filed: 1994-09-21
Granted: 2003-04-07
Abstract: The invention that relates to recombinant raccoon poxvirus useful as a Vaccine Against Feline Infectious Peritonitis Virus Disease. The recombinant raccoon poxvirus has at least one internal gene comprising a DNA sequence encoding a member selected from the group consisting of the nucleocapsid (N) and transmembrane (M/E1) proteins of Feline Infectious Peritonitis Virus (FIPV).
Patent DK-0707580-T3 (DK)
Inventor: LARS AKE KAELLSTROEM
IPC: A61K31/4439
Filed: 1994-07-08
Granted: 2002-04-15
Abstract: A novel compound form of magnesium omeprazole, i.e. with a degree of crystallinity which is higher than 70% as determined by x-ray powder diffraction, useful in the manufacture of pharmaceutical formulations, the use of the product and the process for its production are described.
Patent DK-0731100-T3 (DK)
Inventor: DODGE JEFFREY ALAN
IPC: A61K31/38
Filed: 1996-03-06
Granted: 2000-09-18
Abstract: The present invention provides a compound of formula I <CHEM> wherein R1 is H, OH, halo, OCO(C1-C6 alkyl), OCO(aryl), OSO2(C4-C6 alkyl), OCOO(C1-C6 alkyl), OCOO(aryl), OCONH(C1-C6 alkyl), or OCON(C1-C6 alkyl)2;     R2 is aryl, C1-C6 alkyl, C3-C6 cycloalkyl, or 4-cyclohexanol;     R3 is O(CH2)2 or O(CH2)3; R4 and R5 are optionally CO(CH2)2CH3, CO(CH2)3CH3, C1-C6 alkyl, or R4 and R5 combine to form, with the nitrogen to which they are attached, piperidine, morpholine, pyrrolidine, 3-methylpyrrolidine, 3,3-dimethylpyrrolidine, 3,4-dimethylpyrrolidine, azepine, or pipecoline;     R6 is  &rdurule&  C=CH2 , &rdurule& CH(C1-C5 alkyl),  &rdurule& CH(C2-C5 alkenyl),  &rdurule& C=CH(C1-C5 alkyl), &rdurule& CH(aryl),  &rdurule& C(OH)(C1-C5 alkyl),  &rdurule& C(OH) (C2-C5 alkenyl),  &rdurule& C(OH)aryl;  and pharmaceutically acceptable salts thereof. The present invention further provides pharmaceutical compositions containing compounds of formula I, optionally containing estrogen or progestin, and the use of such compounds alone, or in combination with estrogen or progestin, for alleviating the symptoms of post-menopausal syndrome, particularly osteoporosis, cardiovascular related pathological conditions, and estrogen-dependent cancer. As used herein, the term "progestin" includes compounds having progestational activity such as, for example, progesterone, norethylnodrel, nongestrel, megestrol acetate, norethindrone, and the like. The compounds of the present invention also are useful for inhibiting uterine fibroid disease and endometriosis in women and aortal smooth muscle cell proliferation, particularly restenosis, in humans.
Patent DK-0839192-T3 (DK)
Inventor: DE VROOM ERIK
IPC: C12P37/04
Filed: 1996-07-16
Granted: 2009-04-06
Abstract: A new immobilized Penicillin G acylase with a surprisingly good performance has been provided for. By applying this new immobilized enzyme,  beta -lactam derivatives are prepared in high yield by enzymatic reaction of a parent amino  beta -lactam and a corresponding acylating agent.